Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
13- 10.9Overnight26.10.09 09:004/AOwnership#●●●
Attovia Therapeutics, Inc.
Attovia Therapeutics, Inc. has filed a Form 4/A to amend the reporting of beneficial ownership changes for insider Fu Tao. The filing corrects the details regarding the equity transactions that occurred on August 4, 2026.…more
$13.83-0.07%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.9Overnight26.10.09 09:004/AOwnership
Attovia Therapeutics, Inc.
Attovia Therapeutics, Inc. has filed an amended Form 4/A regarding the statement of changes in beneficial ownership of securities for reporting person Steven Chan, dated August 4, 2026. This filing serves to correct or supplement the previously reported insider share ownership details.…more
$13.83-0.07%vs prev closeView filingShare - 10.8After-hours26.10.09 08:583/AOwnership
Attovia Therapeutics, Inc.
Tao Fu, an officer of Attovia Therapeutics, has filed a Power of Attorney authorizing Steven Chan to execute and file Forms 3, 4, and 5 on his behalf in accordance with Section 16 of the Securities Exchange Act. This is an administrative filing to facilitate the efficient handling of SEC reporting requirements for company insiders.…more
$13.83-0.07%vs prev closeView filingShare
12 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 9.28After-hours26.09.29 05:05#●●●#●●●
Attovia Therapeutics to Present New Clinical Data on ATTO-1310 and ATTO-2306…more
Attovia Therapeutics will present new clinical and preclinical data for its pipeline candidates, ATTO-1310 and ATTO-2306, at upcoming dermatology conferences. These presentations aim to showcase safety, efficacy, and translational data for the company's immune-mediated disease treatments.…more
$13.83-0.07%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 9.3After-hours26.09.04 05:05
●●●●●●●● ●●●●● ●●●●●●
Attovia Therapeutics announced that its management will participate in upcoming investor conferences hosted by Citi and Morgan Stanley. These events will feature meetings and a fireside chat, but do not contain new material business developments.…more
$13.83-0.07%vs prev close - 9.2After-hours26.09.03 05:09
●●●●●●●● ●●●●● ●●●●●●
Attovia Therapeutics reported a Q2 loss per share of $4.88, missing the analyst consensus estimate of $4.62. The company's losses widened significantly compared to the same period last year.…more
$13.83-0.07%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report